Unicycive Therapeutics Inc (UNCY)

Unicycive Therapeutics Inc (UNCY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $92M; returns 1 day -1.3%, 1 week +15.8%, 1 year -20.0%.

Unicycive Therapeutics Inc. (UNCY) is a clinical-stage biotechnology company focused on developing and commercializing novel therapies for kidney diseases. Their lead drug candidate is oxylanthanum carbonate (OLC), a novel phosphate binding agent under FDA review for treating hyperphosphatemia in chronic kidney disease patients on dialysis.

Groups UNCY belongs to

• Biotechnology
• Clinical Stage Biotech
• Nephrology
• Healthcare
• Clinical Stage
• Pharmaceuticals
• 505(b)(2) Pathway
• Unmet Medical Needs
• Rare Diseases

UNCY financial model: income statement, cash flow and balance sheet